<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Benitz S</submitter><funding>National Cancer Institute (NCI)</funding><funding>Deutsche Forschungsgemeinschaft (DFG)</funding><funding>Sky Foundation (THE SKY FOUNDATION)</funding><funding>Sky Foundation</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>National Cancer Institute</funding><funding>Deutsche Krebshilfe</funding><funding>NCI NIH HHS</funding><funding>Deutsche Krebshilfe (German Cancer Aid)</funding><pagination>2162-2182</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11528200</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(11)</volume><pubmed_abstract>Cellular plasticity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) starting from the conversion of normal cells into precancerous lesions, to the progression of carcinoma subtypes associated with aggressiveness and therapeutic response. We discovered that normal acinar cell differentiation, maintained by the transcription factor PDX1, suppresses a broad gastric cell identity that is maintained in metaplasia, neoplasia, and the classical subtype of PDAC in a mouse and human. We identified the receptor tyrosine kinase ROR2 as marker of a gastric metaplasia-like identity in pancreas neoplasms. Ablation of Ror2 in a mouse model of pancreatic tumorigenesis promoted a switch to a gastric pit cell identity that largely persisted through progression to the classical subtype of PDAC. In b</pubmed_abstract><journal>Cancer discovery</journal><pubmed_title>ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma.</pubmed_title><pmcid>PMC11528200</pmcid><funding_grant_id>1F31CA271576</funding_grant_id><funding_grant_id>R01 CA247516</funding_grant_id><funding_grant_id>U01 CA274154</funding_grant_id><funding_grant_id>BE 7224/1-1</funding_grant_id><funding_grant_id>U01CA224145</funding_grant_id><funding_grant_id>R00 CA263154</funding_grant_id><funding_grant_id>U01 CA224145</funding_grant_id><funding_grant_id>F31 CA271576</funding_grant_id><funding_grant_id>R00CA263154</funding_grant_id><funding_grant_id>70115409</funding_grant_id><funding_grant_id>P30 CA045508</funding_grant_id><funding_grant_id>U01CA274154</funding_grant_id><funding_grant_id>R01CA247516</funding_grant_id><funding_grant_id>MA 4115/3-1</funding_grant_id><pubmed_authors>Metzler T</pubmed_authors><pubmed_authors>Benitz S</pubmed_authors><pubmed_authors>Zwernik S</pubmed_authors><pubmed_authors>Steep A</pubmed_authors><pubmed_authors>Bednar F</pubmed_authors><pubmed_authors>Mahajan UM</pubmed_authors><pubmed_authors>Davis ET</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Salas-Escabillas DJ</pubmed_authors><pubmed_authors>Preall J</pubmed_authors><pubmed_authors>Theisen BK</pubmed_authors><pubmed_authors>Song L</pubmed_authors><pubmed_authors>Louw M</pubmed_authors><pubmed_authors>Rempinski D</pubmed_authors><pubmed_authors>McQuithey H</pubmed_authors><pubmed_authors>Wen HJ</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Brender SM</pubmed_authors><pubmed_authors>Long DW</pubmed_authors><pubmed_authors>Regel I</pubmed_authors><pubmed_authors>Steele NG</pubmed_authors><pubmed_authors>Crawford HC</pubmed_authors><pubmed_authors>Nasser MM</pubmed_authors><pubmed_authors>Loveless I</pubmed_authors></additional><is_claimable>false</is_claimable><name>ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma.</name><description>Cellular plasticity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) starting from the conversion of normal cells into precancerous lesions, to the progression of carcinoma subtypes associated with aggressiveness and therapeutic response. We discovered that normal acinar cell differentiation, maintained by the transcription factor PDX1, suppresses a broad gastric cell identity that is maintained in metaplasia, neoplasia, and the classical subtype of PDAC in a mouse and human. We identified the receptor tyrosine kinase ROR2 as marker of a gastric metaplasia-like identity in pancreas neoplasms. Ablation of Ror2 in a mouse model of pancreatic tumorigenesis promoted a switch to a gastric pit cell identity that largely persisted through progression to the classical subtype of PDAC. In b</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T00:25:46.508Z</modification><creation>2025-04-04T22:47:41.827Z</creation></dates><accession>S-EPMC11528200</accession><cross_references><pubmed>38975886</pubmed><doi>10.1158/2159-8290.CD-24-0137</doi></cross_references></HashMap>